Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06394739 · ClinicalTrials.gov registry record
RevCore for In Stent Thrombosis
A clinical trial of In-stent Thrombosis, sponsored by Inari Medical.
- Recruiting
- Registry status
- 100
- Enrollment target
- 15
- Study locations
NCT06394739: Recruiting study of In-stent Thrombosis, sponsored by Inari Medical.
NCT06394739 is a study of In-stent Thrombosis that is actively recruiting participants, run by Inari Medical. The registered enrollment target is 100 participants. The trial reports 15 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06394739, a study of In-stent Thrombosis, is actively recruiting participants, sponsored by Inari Medical.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.
Primary Outcome
Defined as patency ≥50% luminal diameter utilizing intravascular ultrasound (IVUS)
Conditions Studied
Interventions
- DEVICE Thrombectomy
Study Locations (15)
Pennsylvania
- University of Pennsylvania - Philadelphia
- Thomas Jefferson University - Philadelphia
- Allegheny Health Network Research Institute - Pittsburgh
Ohio
- UH Cleveland Medical Center - Cleveland
- Ohio State University - Columbus
Connecticut
- Yale University - New Haven
District of Columbia
- Medstar Health Research Institute - Washington D.C.
Maryland
- University of Maryland - Baltimore
New York
- New York University- Langone - New York
North Carolina
- Mission Health - Asheville
South Carolina
- Spartanburg Medical Center - Spartanburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-09-09 |
| Est. Completion | 2028-04 |
What NCT06394739 shows while recruiting
NCT06394739 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with In-stent Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Thrombectomy is the first listed.
NCT06394739 lists 15 locations in 12 states (Pennsylvania, Ohio, Connecticut).
Frequently Asked Questions
What is clinical trial NCT06394739 about?
NCT06394739 is a clinical study titled "RevCore for In Stent Thrombosis". The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.
What is the current status of trial NCT06394739?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-09-09. Estimated completion is 2028-04.
What conditions does trial NCT06394739 study?
This clinical trial studies the following conditions: In-stent Thrombosis.
What interventions are being tested in trial NCT06394739?
The interventions under investigation include: Thrombectomy (DEVICE).
Who is sponsoring clinical trial NCT06394739?
This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06394739 being conducted?
This trial has 15 study locations across Connecticut, District of Columbia, Maryland, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI